Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection

<p> <br> </p> <p> <b>M.&nbsp;Kh. Khubetsova<sup>1</sup>, V.V. Kadyshev<sup>2</sup>, B.F. Ambalova<sup>3</sup></b> </p> <p> <b><sup>1</sup>S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, R...

Full description

Bibliographic Details
Main Authors: M. Kh. Khubetsova, V.V. Kadyshev, B.F. Ambalova
Format: Article
Language:Russian
Published: Prime-Media 2019-11-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/947/9475b8e35ed0b6e181ae8c62fbb9d478.pdf
id doaj-2394e03d3f22442a96692c2efcbb6786
record_format Article
spelling doaj-2394e03d3f22442a96692c2efcbb67862021-09-16T13:40:14ZrusPrime-Media РМЖ "Клиническая офтальмология"2311-77292619-15712019-11-0119430776Complex treatment approach to primary open-angle glaucoma: focus on neuroprotectionM. Kh. Khubetsova0V.V. Kadyshev1B.F. Ambalova2Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <br> </p> <p> <b>M.&nbsp;Kh. Khubetsova<sup>1</sup>, V.V. Kadyshev<sup>2</sup>, B.F. Ambalova<sup>3</sup></b> </p> <p> <b><sup>1</sup>S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, Russian Federation</b> </p> <p> <b><sup>2</sup>Moscow Genetic Research Center, Moscow, Russian Federation</b> </p> <p> <b><sup>3</sup>Right-Shore Central Regional Clinical Hospital, Beslan, Russian Federation</b> </p> <p> <i>According to the WHO, glaucoma is now the second leading cause of blindness globally. It was demonstrated that effective treatment for glaucoma should include both IOP reduction and neuroprotection. However, even pathogenic treatment for glaucoma can be ineffective due to the poor adherence to treatment. Currently, treatment compliance is of great importance. Ocular surface disorders inevitably resulting from long-term instillations of IOP-lowering medications are among the factors affecting medication non-adherence.</i> </p> <p> <i>Tear replacement therapy is a potential solution which, however, increases the number of medications and instillations and results in poor medication adherence. Brimonidine tartrate 0.2% provides both IOP-lowering and neuroprotective effects while polyvinyl alcohol moisturize and protects ocular surface. Polyvinyl alcohol improves dry eye symptoms in long-term therapy when adding brimonidine to glaucoma treatment.</i> </p> <p> <i><b>Keywords</b>: glaucoma, intraocular pressure, neuroprotection, ocular surface, compliance, brimonidine, Luxfen.</i> </p> <p> <i><b>For citation:</b> Khubetsova M.Kh., Kadyshev V.V., Ambalova B.F. Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection. Russian Journal of Clinical Ophthalmology. 2019;19(4):224–228.</i> </p> <i><br> </i><br>http://clinopht.com/upload/iblock/947/9475b8e35ed0b6e181ae8c62fbb9d478.pdf
collection DOAJ
language Russian
format Article
sources DOAJ
author M. Kh. Khubetsova
V.V. Kadyshev
B.F. Ambalova
spellingShingle M. Kh. Khubetsova
V.V. Kadyshev
B.F. Ambalova
Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
РМЖ "Клиническая офтальмология"
author_facet M. Kh. Khubetsova
V.V. Kadyshev
B.F. Ambalova
author_sort M. Kh. Khubetsova
title Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
title_short Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
title_full Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
title_fullStr Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
title_full_unstemmed Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
title_sort complex treatment approach to primary open-angle glaucoma: focus on neuroprotection
publisher Prime-Media
series РМЖ "Клиническая офтальмология"
issn 2311-7729
2619-1571
publishDate 2019-11-01
description <p> <br> </p> <p> <b>M.&nbsp;Kh. Khubetsova<sup>1</sup>, V.V. Kadyshev<sup>2</sup>, B.F. Ambalova<sup>3</sup></b> </p> <p> <b><sup>1</sup>S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, Russian Federation</b> </p> <p> <b><sup>2</sup>Moscow Genetic Research Center, Moscow, Russian Federation</b> </p> <p> <b><sup>3</sup>Right-Shore Central Regional Clinical Hospital, Beslan, Russian Federation</b> </p> <p> <i>According to the WHO, glaucoma is now the second leading cause of blindness globally. It was demonstrated that effective treatment for glaucoma should include both IOP reduction and neuroprotection. However, even pathogenic treatment for glaucoma can be ineffective due to the poor adherence to treatment. Currently, treatment compliance is of great importance. Ocular surface disorders inevitably resulting from long-term instillations of IOP-lowering medications are among the factors affecting medication non-adherence.</i> </p> <p> <i>Tear replacement therapy is a potential solution which, however, increases the number of medications and instillations and results in poor medication adherence. Brimonidine tartrate 0.2% provides both IOP-lowering and neuroprotective effects while polyvinyl alcohol moisturize and protects ocular surface. Polyvinyl alcohol improves dry eye symptoms in long-term therapy when adding brimonidine to glaucoma treatment.</i> </p> <p> <i><b>Keywords</b>: glaucoma, intraocular pressure, neuroprotection, ocular surface, compliance, brimonidine, Luxfen.</i> </p> <p> <i><b>For citation:</b> Khubetsova M.Kh., Kadyshev V.V., Ambalova B.F. Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection. Russian Journal of Clinical Ophthalmology. 2019;19(4):224–228.</i> </p> <i><br> </i><br>
url http://clinopht.com/upload/iblock/947/9475b8e35ed0b6e181ae8c62fbb9d478.pdf
work_keys_str_mv AT mkhkhubetsova complextreatmentapproachtoprimaryopenangleglaucomafocusonneuroprotection
AT vvkadyshev complextreatmentapproachtoprimaryopenangleglaucomafocusonneuroprotection
AT bfambalova complextreatmentapproachtoprimaryopenangleglaucomafocusonneuroprotection
_version_ 1717378209574551552